Tech giants and biotech experts have raised alarms over gaps in AI safety that could allow synthetic DNA to fall into the wrong hands. A letter signed by CEOs from OpenAI, Anthropic, Microsoft AI, and Google DeepMind, alongside biologists, urges the U.S. Congress to mandate screening for synthetic DNA purchases. The move aims to prevent malicious actors from using the material to recreate dangerous pathogens.
Synthetic DNA is a tool that has transformed medicine and research. It enables the creation of vaccines, engineering of microorganisms, and even data storage. However, the same material can be ordered online and shipped globally, raising concerns. “The ability to order synthetic DNA online has accelerated vaccine development,” the letter notes. “But it also creates a risk.”
Related: Microsoft and Mayo Clinic Unveil New AI
The signatories highlight that while some companies voluntarily screen orders, no legal requirement exists. They argue that mandatory checks are “one of the best understood and least disruptive biosecurity measures.” The letter also calls for record-keeping to trace suspicious activity, not just after incidents but as a deterrent. “So that any threat that might evade initial screening can be traced back to its source,” the document reads.
The urgency stems from rapid AI advancements. Systems now outperform PhD-level virologists in technical lab procedures, lowering the barrier for misuse. Earlier this year, researchers from Johns Hopkins, Oxford, and Stanford warned that unrestricted access to biological datasets could let AI help design dangerous viruses. They called for tools like watermarking and audit logs to prevent misuse.
Related: NOT KNOWN DETAILS ABOUT MDMA
The European Commission’s 2025 EU Biotech Act echoes similar concerns. It labels synthetic nucleic acids as “biotechnology products of concern” and proposes EU-wide rules for customer verification and reporting suspicious orders. The proposal highlights that divergent national laws create loopholes, weakening prevention efforts.
Experts stress that the issue is not new, but AI’s pace of progress amplifies risks. “The knowledge barriers that have historically prevented bad actors from obtaining biological weapons will ‘meaningfully erode,’” the letter states. The call for action spans continents, with the U.S. letter and EU proposals both emphasizing the need for global coordination.
Related: EU and UNICEF send 100 tonnes of Ebola aid to DR Congo
Currently, synthetic DNA purchases are largely unregulated. The letter’s authors argue that without legal mandates, the risk of bioweapons remains unaddressed. They propose measures that balance innovation with security, ensuring traceability without stifling research. “Screening is also one of the best understood and least disruptive biosecurity measures available,” they write.
The debate shows a tension between open science and security. While synthetic DNA has transformed fields, its accessibility demands safeguards. As AI systems grow more capable, the need for regulation becomes sharper. The letter’s signatories and EU officials agree: the time for action is now.